Is recombinant follicle-stimulating hormone more effective in IVF poor responders than human menopausal gonadotrophins?

Medical Science Monitor

Volumn 10, Issue 1, 2004, Pages

  Eskandar, Mamdoh ^a,e   Jaroudi, Kamal ^b   Jambi, Amal ^c   Archibong, Eric I ^d   Coskun, Serdar ^b   Sobande, Adekunle A ^a  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c AL HADA ARMED FORCES HOSPITAL   (Saudi Arabia)

^d Abha Maternity Hospital   (Saudi Arabia)

^e KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

HMG; In vitro fertilization; Poor responders; Pregnancy outcome; RFSH

Indexed keywords

HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BODY MASS; DRUG ACTIVITY; DRUG EFFICACY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OOCYTE; OVARY FOLLICLE; PREGNANCY RATE;

ADULT; CASE-CONTROL STUDIES; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; MALE; MENOTROPINS; OVULATION INDUCTION; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS;

EID: 0842284170     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ben Rafael Z, Feldberg D: The poor responder patients in in-vitro fertilization-embryo transfer program. J. Assist Reprod Genet, 1993; 10: 118-20
2. Padilla SL, Dugan K, Maruschak V et al: Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotrophins regime for in vitro fertilization in poor responders. Fertil Steril, 1996; 65: 796-99
3. Hershlag A, Assis M, Kiamond MP et al: The predictive value and the management of cycles with low initial estradiol levels. Fertil Steril, 1990; 53: 1064-67
4. Dor J, Seidman DS, Amudai E et al: Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: A prospective randomized placebo-controlled double-blind study. Hum Reprod, 1995; 10: 40-43
5. Awonuga A, Nabi A: In vitro fertilization with low-dose clomophene citrate stimulation in women who respond poorly to superovulation. J Assist Reprod Genet, 1997; 14: 503-07
6. Lashen H, Ledger W, Lopez-Bernal A, Barlow D: Superovulation with a high gonadotropin dose for in vitro fertilization: is it effective? J Assist Reprod Genet, 1998; 15: 438-43
7. Bergh C, Howles CM, Borg K et al: Recombinant follicle stimulating hormone (rFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod, 1997; 12: 2133-39
8. Raga F, Bonilla-Musoles F, Casan E, Bonilla F: Recombinant follicle stimulation hormone stimulation in poor responders with normal basal concentrations of follicle stimulation hormone and oestradiol. Hum Reprod, 1999; 14: 1431-34
9. Out HJ, Mannaerts BM, Driessen SG, Coelinh Bennik HJ: A prospective, randomized, assessor-blind, multicenter study comparing recombinant and urinary follicle-stimulation hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod, 1995; 10: 2534-40
10. Fawzy M, Harrison F: Superovulation treatment for in vitro fertilization. Ir Med J, 1994; 87: 188
11. Jansen C, van Os H: Puregon with analogues: an oxymoron. Gynecol Endocrinol, 1996; 10(suppl. 1): 34
12. Daya S, Gunby J, Hughes EG et al: Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in vitro fertilization. Hum Reprod, 1995; 10: 1392-96
13. Pellicer A, Lightman A, Diamond MP et al: Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertil Steril, 1987; 47: 812-15
14. Sills ES, Levy DP, Moomjy M et al: A prospective randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization. Hum Reprod, 1999; 14: 2230-35
15. Out J, Mannaerts B, Driessen S: Recombinant follicle stimulating hormone (r-FSH) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies. Hum Reprod, 1996; 2: 162-71
16. De Placido G, Alviggi C, Mollo A et al: Recombinant follicle stimulation hormone is effective in poor responders to highly purified follicle stimulation hormone. Human Reprod, 2000; 15: 17-20
17. Shoham Z, Mannaerts B, Insler V et al: Induction of follicular growth using recombinant human follicle stimulation hormone in two volunteer women with hypogonadotrophic hypogonadism. Fertil Steril, 1993; 59: 738-42
18. Edwards A: Investing in fertility, Letter to clinicians. Organon Laboratories, Cambridge, England. 1997; 01697G
19. Faber B, Mayer J, Cox B et al: Cessation of gonadotrophin releasing hormone agonist therapy combined with high-dose gonadotrophin stimulation yields favorable pregnancy results in low responders. Fertil Steril, 1998; 5: 826-30
20. Tasdemir M, Tasdemir I, Kodama H et al: Short protocol of gonadotrophin releasing hormone agonist administration gave better results in long protocol poor-responders in IVF-ET. J Obstet Gynaecol, 1996; 22: 73-77